ArticleFrontiers in chemistry2025

Designing novel cabozantinib analogues as p-glycoprotein inhibitors to target cancer cell resistance using molecular docking study, ADMET screening, bioisosteric approach, and molecular dynamics simulations.

Gajendra Singh Thakur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.